🌍 WHO updates HIV clinical management guidelines, prioritizing dolutegravir-based regimens for initial and subsequent treatment, and introducing darunavir/ritonavir as a preferred option when protease inhibitors are needed. Long-acting injectables and simplified oral two-drug regimens are also recommended for specific individuals.

🤱 New guidance strengthens the prevention of vertical HIV transmission, emphasizing person-centered approaches and continued breastfeeding alongside maternal antiretroviral therapy and infant prophylaxis.

💊 For TB prevention in people living with HIV, WHO now recommends a three-month regimen of weekly isoniazid plus rifapentine (3HP) as the preferred option to improve uptake and completion rates.

#HIV #GlobalHealth #AIDS